FauMeda, MB - company info and details

Company age: 3 y. 1 mo.

Update

Company overview

Company name FauMeda, MB
Company code 306440422
VAT code LT100016610418
Registered address Kaunas, Taikos pr. 88A, LT-51183
Registration date 2023-09-22 Company age: 3 y. 1 mo.
Phone Phone
Email Email
Revenue (2025) 3,165,826 € +308% History
Profit (2025) 217,041 € +1% History
Number of employees 13 History
Average salary 2945 € History
Managed vehicles 5 List
Employee turnover rate 196,5 % History
Current SODRA debt 69,838 € Read more
Days of debt to SODRA per year 176 days
Current VMI debt 121,392 € From: 2026-03-20 Read more
Financial statements All submitted
Legal form Small partnership
NACE activity New construction
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
FauMeda, MB (company code 306440422) is an operational private small partnership registered on 22 September 2023. The company is classified as a national private non-financial company with private ownership, where Lithuanian natural and legal persons hold more than 50% of authorised capital and there is no foreign investor capital. Governance is listed as CEO only. FauMeda operates in new construction (EVRK F.41.00.10) and is based in Kaunas, Taikos pr. 88A, Kauno m. sav., Kauno apskr.

In financial year 2025, revenue reached €3.17M, up from €776.4K in 2024, while net profit was €217.0K. Profit margin was 6.9%. Equity at year-end stood at €319.1K, liabilities at €452.0K, and total assets at €771.1K. The company’s size is classified as medium, with revenue in the €2M-€5M range, profit in the €0.1M-€0.5M range, and 51-250 employees.

Average employment increased to 70 so far in 2026, compared with 62 in 2025, and the average monthly wage rose to €2,131.69. Based on 2025 financial data, revenue per employee was €51.1K and profit per employee was €3.5K.

Download a detailed company report

Make confident decisions with all the information about FauMeda, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report